Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 June 2020 | Story Amanda Thongha

WATCH: Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, Prof Hendri Kroukamp, the Dean of the Faculty of Economic and Management Sciences, Susan Van Jaarveld, Senior Director at the Department of Human Sources, and Brandon Jacobs, Head of Retail and Business Banking at Standard Bank, Central Free State explain what the “I Am’ Wellness programme is about.

 

Maintaining a healthy work-life balance continues to be a juggling act for most, more so during this uncertain time dominated by COVID-19. To help individuals cope with life challenges, the University of the Free State (UFS) has launched a new short learning programme that addresses all aspects of well-being.

The ‘I Am’ Wellness short learning programme, open to UFS staff, private individuals, and businesses, kicks off on 19 June 2020. A number of prominent South Africans participating in the launch of the ‘I Am’ Wellness short learning programme are, among others, Kovsie alumna and former Miss World, Rolene Strauss; former Miss South Africa, Amy Kleinhans; and motivational speaker and author, Alison Botha. Former Public Protector Thuli Madonsela rounds off the list of public figures who have also expressed interest in the programme.

Burneline Kaars, Head of Organisational Development and Employee Wellness at the UFS, says those interested in the programme can look forward to content focusing on different topics and themes related to wellness aspects. Participants will discover the fun of finding ways to improve their health and well-being through activities, games, quizzes, and many more.

“Upon completion of this programme, participants will be equipped to understand and improve their own personal and work-related well-being. They will be empowered to increase their own well-being and reach their optimal potential in both their personal and work life.”

The programme, a joint effort of the UFS Division of Organisational Development and Employee Wellness and the UFS Department of Industrial Psychology, can be completed online or as part of contact sessions, depending on the needs of the participants. Participants need to avail themselves four hours a week to successfully complete the programme. Those who master the two-month programme will also receive a certificate of completion from the UFS.

The programme is offered to UFS staff at no cost. External audiences will pay R9 500 per person to complete the programme. Groups of 10 and more will get a special discount when signing up.

Registration for the formal programme opens on Wednesday, 24 June 2020.

For more information, contact Burneline Kaars at KaarsB@ufs.ac.za.


Other programmes done by the UFS Organisational Development and Employee Wellness office:


First #MentalHealth awareness run to Stellenbosch to bring hope
Kovsies pedal smoothie bike for #MentalHealth

 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept